Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leong, S. P.
Right arrow Articles by Katz, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leong, S. P.
Right arrow Articles by Katz, J. A.
Related Collections
Right arrow Sentinel lymph node

Annals of Surgical Oncology, Vol 7, Issue 5 361-366, Copyright © 2000 by Society of Surgical Oncology


ARTICLES

Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma

S. P. Leong, E. Donegan, W. Heffernon, S. Dean and J. A. Katz
Department of Surgery, University of California/Mount Zion Medical Center, San Francisco 94143-1674, USA. leongs@surgery.ucsf.edu

BACKGROUND: Selective sentinel lymph node (SLN) dissection can spare about 80% of patients with primary melanoma from radical lymph node dissection. This procedure identifies the SLN either visually by injecting isosulfan blue dye around the primary melanoma site or by handheld gamma probe after radiocolloid injection. METHODS: During selective SLN mapping, 1 to 5 ml of isosulfan blue was injected intradermally around the primary melanoma. From November 1993, to August 1998, 406 patients underwent intraoperative lymphatic mapping with the use of both isosulfan blue and radiocolloid injection. Three cases of selective SLN dissection, in which adverse reactions to isosulfan blue occurred, were reviewed. RESULTS: We report three cases of anaphylaxis after intradermal injection with isosulfan blue of 406 patients who underwent intraoperative lymphatic mapping by using the procedure as described above. The three cases we report vary in severity from treatable hypotension with urticaria and erythema to severe cardiovascular collapse with or without bronchospasm or urticaria. CONCLUSIONS: In our series, the incidence of anaphylaxis to isosulfan blue was approximately 1%. Anaphylaxis can be fatal if not recognized and treated rapidly. Operating room personnel who participate in intraoperative lymphatic mapping where isosulfan blue is used must be aware of the potential consequences and be prepared to treat anaphylaxis.


This article has been cited by other articles:


Home page
CA Cancer J ClinHome page
S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik
Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
CA Cancer J Clin, September 1, 2006; 56(5): 292 - 309.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. L. Wong, M. S. Brady, K. J. Busam, and D. G. Coit
Results of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma
Ann. Surg. Oncol., March 1, 2006; 13(3): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. G. Dan, S. Saha, K. M. Monson, D. Wiese, E. Schochet, K. R. Barber, B. Ganatra, D. Desai, and S. Kaushal
1% Lymphazurin vs 10% Fluorescein for Sentinel Node Mapping in Colorectal Tumors
Arch Surg, November 1, 2004; 139(11): 1180 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. H. Wong, D. S. Johnson, T. Namiki, and P. Tauchi-Nishi
Validation of Ex Vivo Lymphatic Mapping in Hematoxylin-Eosin Node-Negative Carcinoma of the Colon and Rectum
Ann. Surg. Oncol., August 1, 2004; 11(8): 772 - 777.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. A. King, J. V. Fey, K. J. Van Zee, A. S. Heerdt, M. L. Gemignani, E. R. Port, L. Sclafani, V. Sacchini, J. A. Petrek, H. S. Cody III, et al.
A Prospective Analysis of the Effect of Blue-Dye Volume on Sentinel Lymph Node Mapping Success and Incidence of Allergic Reaction in Patients With Breast Cancer
Ann. Surg. Oncol., May 1, 2004; 11(5): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. P. Raut, M. D. Daley, K. K. Hunt, J. Akins, M. I. Ross, S. E. Singletary, G. D. Marshall Jr, F. Meric-Bernstam, G. Babiera, B. W. Feig, et al.
Anaphylactoid Reactions to Isosulfan Blue Dye During Breast Cancer Lymphatic Mapping in Patients Given Preoperative Prophylaxis
J. Clin. Oncol., February 1, 2004; 22(3): 567 - 568.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Saha, A. G. Dan, B. Berman, D. Wiese, E. Schochet, K. Barber, S. Choudhri, S. Kaushal, B. Ganatra, D. Desai, et al.
Lymphazurin 1% Versus 99mTc Sulfur Colloid for Lymphatic Mapping in Colorectal Tumors: A Comparative Analysis
Ann. Surg. Oncol., January 1, 2004; 11(1): 21 - 26.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
W. R. Wrightson, S. L. Wong, M. J. Edwards, C. Chao, D. S. Reintgen, M. I. Ross, R. D. Noyes, V. Viar, P. B. Cerrito, and K. M. McMasters
Complications Associated With Sentinel Lymph Node Biopsy for Melanoma
Ann. Surg. Oncol., July 1, 2003; 10(6): 676 - 680.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. Simmons, S. Thevarajah, M. B. Brennan, P. Christos, and M. Osborne
Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization
Ann. Surg. Oncol., April 1, 2003; 10(3): 242 - 247.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. Sprung, M. J. Tully, and A. Ziser
Anaphylactic Reactions to Isosulfan Blue Dye During Sentinel Node Lymphadenectomy for Breast Cancer
Anesth. Analg., April 1, 2003; 96(4): 1051 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. P. L. Leong, M. C. Thelmo, R. P. Kim, R. Gokhale, J. Y. Rhee, T. A. Achtem, E. Morita, R. E. Allen Jr, M. Kashani-Sabet, and R. W. Sagebiel
Delayed Harvesting of Sentinel Lymph Nodes After Previous Wide Local Excision of Extremity Melanoma
Ann. Surg. Oncol., March 1, 2003; 10(2): 196 - 200.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. E. Schmidt, E. A. Woltering, W. R. Webb, O. M. Garcia, J. E. Cohen, and M. H. Rozans
Sentinel nodal assessment in patients with carcinoma of the lung
Ann. Thorac. Surg., September 1, 2002; 74(3): 870 - 875.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
T. B. Stefanutto, W. A. Shapiro, and P. M. C. Wright
Anaphylactic reaction to isosulphan blue
Br. J. Anaesth., September 1, 2002; 89(3): 527 - 528.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. L. Montgomery, A. C. Thorne, K. J. Van Zee, J. Fey, A. S. Heerdt, M. Gemignani, E. Port, J. Petrek, H. S. Cody III, and P. I. Borgen
Isosulfan Blue Dye Reactions During Sentinel Lymph Node Mapping for Breast Cancer
Anesth. Analg., August 1, 2002; 95(2): 385 - 388.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. M. Kuerer, K. K. Hunt, S. E. Singletary, and F. C. Ames
Unusual Aspects of Breast Cancer: Case 3. Blue Hives During Lymphatic Mapping for Breast Cancer
J. Clin. Oncol., May 1, 2001; 19(9): 2573 - 2574.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. S. Krouse, R. E. Schwarz, and S. P. L. Leong
Blue Dye for Sentinel Lymph Node Mapping: Not Too Sensitive, but Too Hypersensitive?
Ann. Surg. Oncol., April 1, 2001; 8(3): 268 - 269.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.